Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Cardiovascular safety of evogliptin dual and triple therapy in patients with type 2 diabetes: a nationwide cohort study.

  • Authors : Park S; School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.; Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Metformin*/Metformin*/Metformin*/adverse effects ; Dipeptidyl-Peptidase IV Inhibitors*/Dipeptidyl-Peptidase IV Inhibitors*/Dipeptidyl-Peptidase IV Inhibitors*/adverse effects

  • Source: BMJ open [BMJ Open] 2024 Apr 15; Vol. 14 (4), pp. e077084. Date of Electronic Publication: 2024 Apr 15.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials.

  • Authors : Bansal S; Division of Nephrology, Department of Medicine, University of Texas Health San Antonio, San Antonio, Texas, USA .; Canziani MEF

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Heart Failure*/Heart Failure*/Heart Failure*/complications ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/drug therapy

  • Source: BMJ open [BMJ Open] 2024 Mar 19; Vol. 14 (3), pp. e076444. Date of Electronic Publication: 2024 Mar 19.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Results from a cross-specialty consensus on optimal management of patients with chronic kidney disease (CKD): from screening to complications.

  • Authors : Arici M; Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Hacettepe Universitesi, Ankara, Türkiye .; Assaad-Khalil SH

Subjects: Diabetes Mellitus, Type 2* ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/complications ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/diagnosis

  • Source: BMJ open [BMJ Open] 2024 Mar 07; Vol. 14 (3), pp. e080891. Date of Electronic Publication: 2024 Mar 07.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Clinical characteristics and healthcare utilisation associated with undiagnosed cognitive impairment in elderly patients with diabetes in a primary care setting: a population-based cohort study.

  • Authors : Merzon E; Medical Division, Leumit Health Care Services, Tel Aviv, Israel.; Dr Miriam and Sheldon G Adelson School of Medicine, Ariel University, Ariel, Israel.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: BMJ open [BMJ Open] 2024 Jan 25; Vol. 14 (1), pp. e078996. Date of Electronic Publication: 2024 Jan 25.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Characterising the burden of chronic kidney disease among people with type 2 diabetes in England: a cohort study using the Clinical Practice Research Datalink.

  • Authors : Cook S; National Heart and Lung Institute, Imperial College London, London, UK .; Department of Non-Communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology

  • Source: BMJ open [BMJ Open] 2023 Mar 07; Vol. 13 (3), pp. e065927. Date of Electronic Publication: 2023 Mar 07.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Prevalence and risk factors of chronic kidney disease among patients with type 2 diabetes mellitus at a tertiary care hospital in Nepal: a cross-sectional study.

  • Authors : Joshi R; Department of Internal Medicine, Shree Birendra Hospital; Nepalese Army Institute of Health Sciences, Kathmandu, Nepal.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/complications

  • Source: BMJ open [BMJ Open] 2023 Feb 28; Vol. 13 (2), pp. e067238. Date of Electronic Publication: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Leveraging the South African Diabetes Prevention Programme to screen for chronic kidney disease: an observational study.

  • Authors : George C; Non-Communicable Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa .; Hill J

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/diagnosis ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/prevention & control ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology

  • Source: BMJ open [BMJ Open] 2023 Jan 06; Vol. 13 (1), pp. e068672. Date of Electronic Publication: 2023 Jan 06.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Cardiovascular and renal efficacy and safety of sodium-glucose cotransporter-2 inhibitors in patients without diabetes: a systematic review and meta-analysis of randomised placebo-controlled trials.

  • Authors : Tsai WC; Division of Nephrology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.; Center for General Education, Lee-Ming Institute of Technology, New Taipei City, Taiwan.

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/chemically induced ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications

  • Source: BMJ open [BMJ Open] 2022 Oct 14; Vol. 12 (10), pp. e060655. Date of Electronic Publication: 2022 Oct 14.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus (LEGEND-T2DM): a protocol for a series of multinational, real-world comparative cardiovascular effectiveness and safety studies.

  • Authors : Khera R; Section of Cardiovascular Medine, Yale School of Medicine, New Haven, Connecticut, USA.; Center for Outcomes Research and Evaluation, Yale University School of Medicine, New Haven, Connecticut, USA.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/chemically induced ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Dipeptidyl-Peptidase IV Inhibitors*/Dipeptidyl-Peptidase IV Inhibitors*/Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use

  • Source: BMJ open [BMJ Open] 2022 Jun 09; Vol. 12 (6), pp. e057977. Date of Electronic Publication: 2022 Jun 09.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  765 results for ""Diabetes Mellitus, Type 2""